A detailed history of Jpmorgan Chase & CO transactions in Enovis Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 190,523 shares of ENOV stock, worth $8.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190,523
Previous 300,190 36.53%
Holding current value
$8.62 Million
Previous $13.6 Million 39.55%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$40.57 - $48.1 $4.45 Million - $5.27 Million
-109,667 Reduced 36.53%
190,523 $8.2 Million
Q2 2024

Aug 12, 2024

BUY
$44.56 - $62.43 $3.64 Million - $5.09 Million
81,595 Added 37.33%
300,190 $13.6 Million
Q1 2024

May 10, 2024

BUY
$55.44 - $63.8 $2.66 Million - $3.07 Million
48,064 Added 28.18%
218,595 $13.7 Million
Q4 2023

Feb 12, 2024

BUY
$43.67 - $57.07 $1.38 Million - $1.8 Million
31,627 Added 22.77%
170,531 $9.55 Million
Q3 2023

Nov 14, 2023

SELL
$51.65 - $65.54 $338,927 - $430,073
-6,562 Reduced 4.51%
138,904 $7.32 Million
Q2 2023

Aug 11, 2023

SELL
$52.7 - $64.12 $39,525 - $48,090
-750 Reduced 0.51%
145,466 $9.33 Million
Q1 2023

May 18, 2023

BUY
$49.5 - $65.92 $4.05 Million - $5.4 Million
81,893 Added 127.32%
146,216 $7.82 Million
Q1 2023

May 11, 2023

SELL
$49.5 - $65.92 $2.12 Million - $2.82 Million
-42,851 Reduced 39.98%
64,323 $3.44 Million
Q4 2022

Feb 13, 2023

SELL
$44.83 - $57.43 $493,488 - $632,189
-11,008 Reduced 9.31%
107,174 $5.74 Million
Q3 2022

Nov 14, 2022

BUY
$46.07 - $60.1 $777,523 - $1.01 Million
16,877 Added 16.66%
118,182 $5.44 Million
Q2 2022

Aug 11, 2022

BUY
$55.0 - $70.47 $5.57 Million - $7.14 Million
101,305 New
101,305 $5.57 Million

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.45B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.